Watchlist Price Alert

NovaBay Pharmaceuticals I... (NBY)

AMEX: NBY · Real-Time Price · USD

0.59

0.00 (0.05%)

At close: Jun 06, 2025, 3:59 PM

0.57

-2.78%

After-hours: Jun 06, 2025, 05:18 PM EDT

NovaBay Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	9.78M	14.73M	14.4M	8.42M	9.93M	6.6M	12.51M	18.23M	11.9M
Cost of Revenue	3.3M	6.83M	6.62M	2.78M	3.97M	1.74M	1.5M	2.78M	2.46M
Gross Profit	6.48M	6.08M	7.78M	5.64M	5.96M	4.86M	11.01M	15.45M	9.43M
Operating Income	-5.84M	-5M	-7.68M	-8.86M	-6.43M	-9.4M	-7.87M	-7.31M	-10.98M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.21M	-9.64M	-10.61M	-5.82M	-11.03M	-9.65M	-6.54M	-7.4M	-13.15M
Net Income	-7.22M	-9.64M	-16.27M	-6.56M	-11.04M	-10.49M	-6.54M	-7.4M	-13.15M
Selling & General & Admin	11.41M	12.83M	15.29M	14.46M	12.11M	14.08M	18.62M	22.35M	19.04M
Research & Development	42K	68K	174K	44K	285K	184K	259K	410K	1.37M
Other Expenses	865K	n/a	-276K	-1.58M	605K	-1.43M	19K	12K	-68K
Operating Expenses	12.32M	12.9M	15.46M	14.51M	12.39M	14.26M	18.88M	22.76M	20.41M
Interest Expense	904K	1.69M	n/a	n/a	n/a	1.05M	n/a	n/a	n/a
Selling & Marketing Expenses	4.03M	6.5M	7.8M	7.22M	6.17M	8.77M	12.79M	13.71M	11.81M
Cost & Expenses	14.72M	19.73M	22.08M	17.28M	16.36M	16M	20.38M	25.54M	22.88M
Income Tax Expense	n/a	n/a	-3.81M	-4.62M	5K	6K	4K	3K	2K
Shares Outstanding (Basic)	3.4M	120K	30K	31.64K	28.63K	16.27K	11.6K	12.51K	12.42K
Shares Outstanding (Diluted)	3.4M	120K	46K	35.63K	28.63K	17.67K	13.93K	12.51K	12.55K
EPS (Basic)	-2.53	-139.14	-353.59	-184.09	-385.53	-593.63	-473.83	-591.81	-1.06K
EPS (Diluted)	-2.53	-138.65	-353.59	-184.09	-385.53	-593.63	-564.17	-591.81	-1.05K
EBITDA	-5.92M	-4.8M	-7.2M	-8.74M	-6.38M	-9.34M	-7.61M	-7.22M	-10.87M
EBIT	-6.31M	-5M	-7.68M	-8.86M	-6.43M	-9.4M	-7.87M	-7.31M	-10.98M
Depreciation & Amortization	381K	203K	483K	119K	51K	65K	266K	95K	114K